Construct: ORF TRCN0000467740
Construct Description:
- Construct Type:
- ORF
- Other Identifiers:
- ORF003801.1_s317c1
- Derived from:
- ccsbBroadEn_06449
- DNA Barcode:
- TATGAGTATTCTCCACCACAGTTG
- Epitope Tag:
- V5
- Notes:
- No stop codon in insert
Originally Annotated References:
- Gene:
- ILF3 (3609)
Vector Information:
- Vector Backbone:
- pLX_317
- Pol II Cassette 1:
- SV40-PuroR
- Pol II Cassette 2:
- EF1a-TRCN0000467740
- Selection Marker:
- PuroR
- Visible Reporter:
- n/a
- Epitope Tag:
- V5
Current transcripts matched by this ORF:
| Taxon | Gene | Symbol | Description | Transcript | Nuc. Match %[?]A simple nucleotide-based global alignment percentage, calculated as follows: total nt. matches ---------------------------------- aligned length (incl. gaps) |
Prot. Match %[?]A simple amino acid-based global alignment percentage, calculated as follows: total aa. matches ---------------------------------- aligned length (incl. gaps) |
Match Diffs[?]This field may contain sequence annotations in HGVS format. For more information about HGVS annotations, please refer to the HGVS Quick Reference Guide. | |
|---|---|---|---|---|---|---|---|---|
| 1 | human | 3609 | ILF3 | interleukin enhancer bindin... | NM_001137673.2 | 99.9% | 100% | 2055G>T |
| 2 | human | 3609 | ILF3 | interleukin enhancer bindin... | NM_004516.4 | 99.3% | 99.4% | 1546_1547insAGAACGTAAAAC;2043G>T |
| 3 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_024451490.1 | 99.3% | 99.4% | 1546_1547insAGAACGTAAAAC;2043G>T |
| 4 | human | 3609 | ILF3 | interleukin enhancer bindin... | NM_153464.3 | 97.4% | 97.3% | (many diffs) |
| 5 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_011527985.2 | 89.4% | 88.6% | (many diffs) |
| 6 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_006722742.2 | 81.3% | 81% | (many diffs) |
| 7 | human | 3609 | ILF3 | interleukin enhancer bindin... | NM_017620.2 | 77.4% | 77.2% | (many diffs) |
| 8 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_011527984.2 | 77.4% | 77.2% | (many diffs) |
| 9 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_017026763.1 | 77.4% | 77.2% | (many diffs) |
| 10 | human | 3609 | ILF3 | interleukin enhancer bindin... | NM_012218.4 | 77% | 76.7% | (many diffs) |
| 11 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_024451491.1 | 48% | 47.7% | (many diffs) |
| 12 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_011527987.1 | 40.3% | 40% | (many diffs) |
| 13 | human | 3609 | ILF3 | interleukin enhancer bindin... | XM_017026765.1 | 40.3% | 40% | (many diffs) |
| 14 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | NM_001042709.2 | 87.2% | 94.9% | (many diffs) |
| 15 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313144.1 | 86.6% | 94.1% | (many diffs) |
| 16 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | NM_001042708.2 | 85.6% | 93% | (many diffs) |
| 17 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313140.1 | 77.7% | 84% | (many diffs) |
| 18 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313141.1 | 77.2% | 83.4% | (many diffs) |
| 19 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313139.1 | 76.4% | 82.6% | (many diffs) |
| 20 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_011242405.2 | 75.9% | 82% | (many diffs) |
| 21 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | NM_001042707.2 | 67.4% | 73% | (many diffs) |
| 22 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_006510031.2 | 67.4% | 73% | (many diffs) |
| 23 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_006510029.3 | 67% | 72.5% | (many diffs) |
| 24 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_006510030.2 | 67% | 72.5% | (many diffs) |
| 25 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | NM_001277321.1 | 66.6% | 72.1% | (many diffs) |
| 26 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | NM_001277322.1 | 66.4% | 71.8% | (many diffs) |
| 27 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | NM_010561.3 | 66.4% | 71.8% | (many diffs) |
| 28 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_011242403.2 | 66.1% | 71.5% | (many diffs) |
| 29 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313138.1 | 62.3% | 67.8% | (many diffs) |
| 30 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_011242404.2 | 61.1% | 66.4% | (many diffs) |
| 31 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_006510034.3 | 50.1% | 54.4% | (many diffs) |
| 32 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313142.1 | 50.1% | 54.4% | (many diffs) |
| 33 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313143.1 | 50.1% | 54.4% | (many diffs) |
| 34 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_006510036.3 | 41.4% | 44.9% | (many diffs) |
| 35 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313145.1 | 41.4% | 44.9% | (many diffs) |
| 36 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_006510037.3 | 34.2% | 37.2% | (many diffs) |
| 37 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313146.1 | 34.2% | 37.2% | (many diffs) |
| 38 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313147.1 | 34.2% | 37.2% | (many diffs) |
| 39 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313148.1 | 34.2% | 37.2% | (many diffs) |
| 40 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313149.1 | 34.2% | 37.2% | (many diffs) |
| 41 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313150.1 | 34.2% | 37.2% | (many diffs) |
| 42 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313151.1 | 34.2% | 37.2% | (many diffs) |
| 43 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XM_017313152.1 | 34.2% | 37.2% | (many diffs) |
| 44 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XR_001778803.1 | 32.6% | (many diffs) | |
| 45 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XR_001778802.1 | 32.3% | (many diffs) | |
| 46 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XR_001778801.1 | 29.7% | (many diffs) | |
| 47 | mouse | 16201 | Ilf3 | interleukin enhancer bindin... | XR_001778804.1 | 27.4% | (many diffs) |
Sequence Information
Note: uppercase bases indicate empirically verified sequence.
- ORF start:
- 66
- ORF end:
- 2184
- ORF length:
- 2118
- Sequence:
-
1 tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag 61 ttggcatgcg tccaatgcga atttttgtga atgatgaccg ccatgtgatg gcaaagcatt 121 cttccgttta tccaacacaa gaggagctgg aggcagtcca gaacatggtg tcccacacgg 181 agcgggcgct caaagctgtg tccgactgga tagacgagca ggaaaagggt agcagcgagc 241 aggcagagtc cgataacatg gatgtgcccc cagaggacga cagtaaagaa ggggctgggg 301 aacagaagac ggagcacatg accagaaccc tgcggggagt gatgcgggtg ggcctggtgg 361 caaagggcct cctactcaag ggggacttgg atctggagct ggtgctgctg tgtaaggaga 421 agcccacaac cgccctcctg gacaaggtgg ccgacaacct ggccatccag cttgctgctg 481 taacagaaga caagtacgaa atactgcaat ctgtcgacga tgctgcgatt gtgataaaaa 541 acacaaaaga gcctccattg tccctgacca tccacctgac atcccctgtt gtcagagaag 601 aaatggagaa agtattagct ggagaaacgc tatcagtcaa cgaccccccg gacgttctgg 661 acaggcagaa atgccttgct gccttggcgt ccctccgaca cgccaagtgg ttccaggcca 721 gagccaacgg gctgaagtct tgtgtcattg tgatccgggt cttgagggac ctgtgcactc 781 gcgtgcccac ctggggtccc ctccgaggct ggcctctcga gctcctgtgt gagaaatcca 841 ttggcacggc caacagaccg atgggtgctg gcgaggccct gcggagagtg ctggagtgcc 901 tggcgtcggg catcgtgatg ccagatggtt ctggcattta tgacccttgt gaaaaagaag 961 ccactgatgc tattgggcat ctagacagac agcaacggga agatatcaca cagagtgcgc 1021 agcacgcact gcggctcgct gccttcggcc agctccataa agtcctaggc atggaccctc 1081 tgccttccaa gatgcccaag aaaccaaaga atgaaaaccc agtggactac accgttcaga 1141 tcccaccaag caccacctat gccattacgc ccatgaaacg cccaatggag gaggacgggg 1201 aggagaagtc gcccagcaaa aagaagaaga agattcagaa gaaagaggag aaggcagagc 1261 ccccccaggc tatgaatgcc ctgatgcggt tgaaccagct gaagccaggg ctgcagtaca 1321 agctggtgtc ccagactggg cccgtccatg cccccatctt taccatgtct gtggaggttg 1381 atggcaattc attcgaggcc tctgggccct ccaaaaagac ggccaagctg cacgtggccg 1441 ttaaggtgtt acaggacatg ggcttgccga cgggtgctga aggcagggac tcgagcaagg 1501 gggaggactc ggctgaggag accgaggcga agccagcagt ggtggcccct gccccagtgg 1561 tagaagctgt ctccacccct agtgcggcct ttccctcaga tgccactgcc gagaacgtaa 1621 aacagcaggg gccgatcctg acaaagcacg gcaagaaccc agtcatggag ctgaacgaga 1681 agaggcgtgg gctcaagtac gagctcatct ccgagaccgg gggcagccac gacaagcgct 1741 tcgtcatgga ggtcgaagtg gatggacaga agttccaagg tgctggttcc aacaaaaagg 1801 tggcgaaggc cTACGCTGCT CTTGCTGCCC TAGAAAAGCT TTTCCCTGAC ACCCCTCTCG 1861 CCCTTGATGC CAACAAAAAG AAGAGAGCCC CAGTACCCGT CAGAGGGGGA CCGAAATTTG 1921 CTGCTAAGCC ACATAACCCT GGCTTCGGCA TGGGAGGCCC CATGCACAAC GAAGTGCCCC 1981 CACCCCCCAA CCTTCGAGGG CGGGGAAGAG GCGGGAGCAT CCGGGGACGA GGGCGCGGGC 2041 GAGGATTTGG TGGCGCCAAC CATGGAGGCT ACATGAATGC CGGTGCTGGG TATGGAAGCT 2101 ATGGGTACGG AGGCAACTCT GCGACAGCAG GCTACAGTGA CTTTTTCACA GACTGCTACG 2161 GCTATCATGA TTTTGGGTCT TCCTACCCAA CTTTCTTGTA CAAAGTGGTT GATATCGGTA 2221 AGCCTATCCC TAACCCTCTC CTCGGTCTCG ATTCTACGTA GTAATGAACT AGTCCGTAAC 2281 TTGAAAGTAT TTCGATTTCT TGGCTTTATA TATCTTGTGG AAAGGACGAT ATGAGTATTC 2341 TCCACCACAG TTGACGCGTT AAGTCgacaa tcaacctctg gattacaaaa tttgtgaaag 2401 att